Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Bio Laboratories as its exclusive distributor in Singapore.
Sunnyvale, CA — July 21, 2009 — Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Bio Laboratories as its exclusive distributor in Singapore.
“We are pleased to renew and expand our relationship with Bio Laboratories,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we grow in Asia, Bio Laboratories’ experience will help us reach users in our established market of pharmaceutical drug discovery as well as the expanding genomics market. We expect Bio Laboratories will play an important role as we increase our presence into the Asian markets.”
“Labcyte has amazing and innovative tools that will meet the needs of our customers in multiple fields of research,” said Mr. Benny Wee, Managing Director at Bio Laboratories. “We see a significant market for low-volume transfer devices in Singapore. We believe that the growing genomics markets, especially for gene expression, SNP analysis and RNAi, will find that the need for miniaturization is met especially well by the Labcyte technologies. We also think that researchers in the growing pharmaceutical presence in Singapore will find that their compound management and high-throughput screening needs are best met by the Labcyte acoustic technologies that are quickly becoming a standard in much of Europe and the U.S.”
“As more people move to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential,” said Nick Samaras, Managing Director, Asia-Pacific from his office in Melbourne. “In particular, our Echo®
liquid handler provides better results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”
About Bio Laboratories.
Bio Laboratories is a leading distributor of medical, scientific and life science products in Singapore. They focus on serving customers through the innovative and responsible application of science and technology. Bio Laboratories is proud of its efficient service and technical service support. For more information, visit www.biolab.com.sg
About Labcyte Inc.
Labcyte Inc. uses sound to move liquids. This green technology provides significantly better analytical results while saving money. The ‘touchless’ technology provides dramatically better answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Together with the Deerac systems, the award-winning Echo® liquid handlers are used in all of the top 10 pharmaceutical companies, as well as in leading academic and research institutions worldwide. Labcyte technologies have broad applications including the fields of compound management, genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer. Labcyte is headquartered in Sunnyvale, California with offices in Dublin, Ireland and has 39 U.S., 7 European and two Japanese patents and additional U.S. and international filings. For more information, visit www.labcyte.com